Sfoglia per AUTORE
CHIARENZA A
Collezione ASL Asti

  

Items : 3

Efficacy and safety of front-line treatment with ibrutinib and rituximab in unfit patients with chronic lymphocytic leukemia (CLL). First report of the GIMEMA LLC1114 study in Haematologica

2019
ASL Asti
AO Ordine Mauriziano

Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati M; Gottardi D; Re F; Ilariucci F; Zinzani PL; Mannina D; Gozzetti A; Molinari AL; Gentile M; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Murru R; Tani M; et alii...

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

2018
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Eyre TA; Kennedy B; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Re F; Gaidano G; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Amendola A; Billio A; Visco C; Mauro FR; Galieni P; Orlandi EM; Farina L; Delgado AR; Musuraca G; Laurenti L; Coscia M; Perez AM; et alii...

Efficacy and safety of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia: Results of the GIMEMA-ERIC LLC1315 study in Blood

2017
ASL Asti

Ghia P; Foa R; Follows GA; De La Serna J; Vignetti M; Gaidano G; Ilariucci F; Meneghini V; Chiarenza A; González M; Re F; Marchetti M; Marasca R; Pizzuti M; Visco C; Ciolli S; Orlandi EM; Rivas-Delgado A; Farina L; Musuraca G; Coscia M; Perez AM; Trentin L; Gentile M; Montillo M; Molica S; Mauro FR; Laurenti L; Galieni P; et alii...